Antiviral drug for post-transplant complications now costs more than the transplant
June 2, 2016
| By Mary Engel / Fred Hutch News Service
A life-saving antiviral drug used to treat a type of severe pneumonia in children and adults who have undergone bone marrow transplants can now cost more than the transplant itself after the drug’s sole distributor, Valeant Pharmaceuticals, increased the price by almost 400 percent.
Guang-Shing Cheng helps immunocompromised patients with respiratory illnesses, aims to detect lung cancer earlier
April 30, 2012
| By Colleen Steelquist
Dr. Guang-Shing Cheng has joined the Fred Hutchinson Cancer Research Center's Clinical Research Division faculty. Her research focuses on improving outcomes for stem cell transplant patients with respiratory failure and on advancing diagnostic strategies for early detection of lung infections and cancer.